Search Results for "Fingolimod Hplc Method"

17:01 EST 10th February 2016 | BioPortfolio

Matching Channels


Fluorescent in situ hybridization (FISH) is a sensitive and accurate technique that allows the detection of chromosome aberrations. In this method, a single-stranded fluorescent-labeled nucleic acid...

Spirometry Test

The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...

Herpes simplex virus HSV 1 HSV 2 HHV 1 HHV 2

Herpes simplex virus 1 and 2 (HSV-1 and HSV-2), also known as Human herpes virus 1 and 2 (HHV-1 and -2), are two members of the herpes virus family that infect humans. HSV-1 and HSV-2 cause the vira...

Breast Implants - Augmentation

Breast implants are medical devices that are used to augment breast size or to reconstruct the breast following mastectomy or to correct a congenital abnormality. Breast implants consist of a silico...


ImuXen® is a liposomal technology platform designed to improve the delivery and effectiveness of DNA, protein and polysaccharide vaccines. Proof of concept preclinical studies with a number of...

Matching News

Intelligent Solutions for UHPLC / HPLC Method Development – ACE Method Development Kits

ACE Method Development Kits are designed to maximise selectivity – the key to resolution in chromatography.  A complete range of kits for all requirements is available, including kits feat...

New EMA Advice for PML Prevention With Fingolimod in MS

The European Medicines Agency recommends evaluating patients for progressive multifocal leukoencephalopathy and for basal cell carcinoma before and during treatment with fingolimod (Gilenya). News A...

Third Case of PML With Fingolimod (Gilenya) in MS

Novartis reports a third case of progressive multifocal leukoencephalopathy in a patient with relapsing multiple sclerosis treated with fingolimod. News Alerts

FDA issues new PML warning for fingolimod

The US Food and Drug Administration has issued a new safety warning about cases of a rare brain infection in multiple sclerosis patients taking fingolimod (Gilenya).

Switching From Natalizumab to Fingolimod in RRMS

This study aims to improve our understanding of drug-induced immune changes and potential disease exacerbation during switch-over from natalizumab to fingolimod in treatment of RRMS. BMC Neurology

Chilling/Heating HPLC Column Temperature Controller

Torrey Pines Scientific, Inc. announces its new EchoTherm Model CO50 Programmable HPLC Column Chiller/Heater. The unit has a temperature range from 4.0°C to 100.0°C readable and settable to 0.1°C. ...

Gilenya (fingolimod): Drug Safety Communication - FDA Warns About Cases of Rare Brain Infection

Audience: Neurology, Pharmacy [Posted 08/04/2015] ISSUE: FDA is warning that a case of definite progressive multifocal leukoencephalopathy (PML) and a case of probable PML have been reported in patie...

FDA Drug Safety Communication: FDA warns about cases of rare brain infection with MS drug Gilenya (fingolimod) in two patients with no prior exposure to immunosuppressant drugs

[07-04-2015] The U.S. Food and Drug Administration is warning that a case of definite progressive multifocal leukoencephalopathy (PML) and a case of probable PML have been reported in patients taking...

Matching PubMed Articles

Effects of Three Months Fingolimod Therapy on Heart Rate.

Fingolimod is a novel disease-modifying drug for relapsing-remitting multiple sclerosis (RRMS). Fingolimod initiation associates with a decrease in heart rate (HR). However, the long-term effects of f...

Effect of fingolimod on cardiac autonomic regulation in patients with multiple sclerosis.

Fingolimod modulates sphingosine-1-phosphate receptors that are also found in cardiovascular tissue.

Fingolimod Prescribed for the Treatment of Multiple Sclerosis in Patients Younger than Age 18 Years.

There have been no clinical trials for approval of medications for treating multiple sclerosis in patients younger than age 18 years. All treatments are based on personal experience and data from ope...

Development of a HPLC Method for the Quantitative Determination of Capsaicin in Collagen Sponge.

Controlling the concentration of drugs in pharmaceutical products is essential to patient's safety. In this study, a simple and sensitive HPLC method is developed to quantitatively analyze capsaicin i...

Fingolimod Real World Experience: Efficacy and Safety in Clinical Practice.

Fingolimod is a multiple sclerosis treatment licensed in Europe since 2011. Its efficacy has been demonstrated in three large phase III trials, used in the regulatory submissions throughout the world....

Search Whole site using Google

Quick Search
Advertisement Advertisement